Targeted Treatments and Immunotherapy for Solid Tumours: Demystifying the Science
Event date and time: 18 February 2025, 9:30 am to 12:30 pm
Who should attend:
This content is ideal for research nurses, clinical nurse specialists, pharmacists, and clinical trials coordinators. It may also interest other healthcare professionals wanting to improve their understanding of targeted treatments and immunotherapy.
This course gives cancer nurses and trial staff the knowledge and confidence to discuss a wide range of targeted cancer treatments and immunotherapies with patients and colleagues.
Overview
This course focuses on cancer biology and the science behind licensed treatments for solid tumours, including monoclonal antibodies, small molecule kinase inhibitors, and immunotherapies.
Over the course of two mornings, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – will guide you through the scientific concepts that underpin many of the most used targeted cancer treatments and immunotherapies for solid tumours.
Treatments discussed include those that target cell communication pathways (e.g. EGFR and HER2-targeted treatments) and immune checkpoint inhibitors. Elaine also describes various molecular features of cancer that underpin many other new treatments.